Adcytherix

About:

Adcytherix is a biopharmaceutical firm that specializes in the development of new antibody drug conjugates (ADC).

Top Investors: RA Capital Management, Pontifax, Pureos Bioventures, Dawn Biopharma

Description:

Adcytherix is a biopharmaceutical firm that specializes in the development of new antibody drug conjugates (ADC) to treat diseases with a high unmet need, including cancer.

Total Funding Amount:

30M EUR

Headquarters Location:

Marseille, Provence-Alpes-Cote d'Azur, France

Founded Date:

2023-01-01

Founders:

Carsten Dehning, Jack Elands

Number of Employees:

1-10

Last Funding Date:

2024-06-11

IPO Status:

Private

Industries: